紙本診斷市場：現況分析與預測（2023-2030）

Paper Diagnostics Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年04月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計 2023 年至 2030 年，紙本診斷市場的複合年增長率約為 8.2%。紙本診斷通常透過印刷、點樣和固定等各種技術將抗體、核酸和酵素等生物分子識別元件整合到紙質基材中。紙張可作為固體支撐基質，用於進行生化反應並捕獲生物樣本（例如血液、尿液、唾液和環境樣本）中存在的目標分析物。心臟病、心臟衰竭、心肌梗塞、肝臟疾病和其他慢性疾病等心血管疾病的流行是紙本診斷市場的關鍵驅動因素。由於這些疾病持續影響全球很大一部分人口，因此對這些疾病的診斷和監測的需求仍然很高。例如，到2024年，全球約有6.2億人將患有心臟和循環系統疾病。據估計，全世界每 13 人就有 1 人患有心臟病或循環系統疾病。此外，技術進步也促使了更靈敏、更特異的紙本診斷試劑盒的開發。

根據試劑盒類型，市場分為側流檢測、試紙和紙基微流體。預計量油尺類別在預測期內將佔據最高佔有率。量油尺因其簡單性、多功能性和適用於現場檢測應用而在紙本診斷市場中不斷增長。基於試紙的測試通常涉及將紙條（試紙）浸入含有目標分析物的樣本中，其中發生特定的生化反應，產生可見的顏色變化，表明分析物的存在或濃度。例如，2021 年，幾家公司正在開發基於試紙的抗原測試，以快速檢測導致 COVID-19 的 SARS-CoV-2 病毒。這些測試為大流行期間的大規模篩檢和監測活動提供了方便且經濟高效的解決方案。

根據設備類型，紙本診斷市場分為診斷設備、監測設備。其中，由於多種因素推動了對創新和可靠診斷技術的需求，診斷設備領域的紙本診斷市場正在成長。診斷設備包括用於執行診斷測試、分析樣本和解釋結果的各種儀器、平台和系統。這些設備能夠準確、及時地診斷各種醫療狀況，在醫療保健服務中發揮重要作用。此外，人們越來越認識到預防性保健和早期發現疾病的重要性，因此重視篩檢計劃和定期健康檢查。

依應用劃分，市場分為臨床診斷、食品品質檢測和環境監測。預計臨床診斷類別在預測期內將表現出最高的複合年增長率。在紙本診斷市場中，臨床診斷是指應用紙本診斷測試和設備來診斷、監測和管理臨床環境中的各種狀況和疾病。臨床診斷包括廣泛的應用，包括傳染病檢測、慢性病管理、癌症篩檢以及生物標記和生理參數的監測。

依最終用戶劃分，紙本診斷市場分為家庭醫療保健、輔助生活醫療保健設施、醫院/診所等。其中，醫院/診所類別預計在預測期內紙本診斷的採用率將會增加。由於多種因素推動了醫療環境中對快速、經濟高效且易於使用的診斷解決方案的需求，紙本診斷市場的最終用戶醫院和診所部分正在成長。醫院和診所是尋求診斷、治療和管理各種醫療狀況的患者的初級保健中心。此外，對快速診斷、治療監測和患者管理的需求正在推動醫院和診所對即時檢測的需求。紙本診斷測試具有快速週轉時間、易於使用和便攜等優點，使其適合醫療保健環境中的現場護理測試應用。

為了更瞭解紙本診斷產業的市場實施情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞太地區（中國、日本、印度、亞太其他地區）和世界其他地區。北美紙本診斷市場的推動因素包括心血管疾病、肝損傷和糖尿病等慢性病的盛行率不斷上升、醫療保健專業人員和公眾對紙本診斷的認識不斷提高、先進技術的發展以及治療範圍的擴大預計市場將因這一增長而繼續增長。例如，根據 CDC 的數據，2019 年，美國每年約有 805,000 人心臟病發作。大約五分之一的心臟病發作者沒有任何症狀，這意味著傷害已經造成，但患者並沒有意識到。

市場主要參與者包括Bio-Rad Laboratories, Inc.、BIOMERIEUX.、Abbott、Siemens Healthcare Private Limited、Micro Essential Laboratory Inc、Abingdon Health、AnteoTech、Bioneer Corporation、EKF Diagnostics Holdings plc、Acon Laboratories, Inc.等。

The Paper Diagnostics market is expected to register a CAGR of approx. 8.2% over the period of 2023-2030. Paper diagnostics typically involve the integration of biomolecular recognition elements, such as antibodies, nucleic acids, or enzymes, onto paper substrates through various techniques, such as printing, spotting, or immobilization. The paper serves as a solid support matrix for conducting biochemical reactions and capturing target analytes present in biological samples, such as blood, urine, saliva, or environmental samples. The prevalence of cardiovascular diseases, such as heart attacks, heart failure, and myocardial infarctions, liver disorder and other chronic diseases are significant drivers of the paper diagnostics market. As these conditions continue to affect a large portion of the population globally, the demand for diagnosing and monitoring these diseases remains high. For instance, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. Globally it is estimated that 1 in 13 people are living with a heart or circulatory disease. Furthermore, advances in technology have led to the development of more sensitive and specific paper diagnostics kits.

Based on Kit Type, the market is segmented into lateral flow assays, dipsticks, and paper-based microfluidics. The dipsticks category is expected to witness the highest share during the forecast period. Dipsticks are experiencing growth in the paper diagnostic market due to their simplicity, versatility, and suitability for point-of-care testing applications. Dipstick-based assays typically involve immersing a paper strip (the dipstick) into a sample containing the target analyte, where specific biochemical reactions occur and result in a visible color change, indicating the presence or concentration of the analyte. For instance, in 2021, several companies have developed dipstick-based antigen tests for rapid detection of SARS-CoV-2, the virus that causes COVID-19. These tests offer a convenient and cost-effective solution for mass screening and surveillance efforts during the pandemic.

Based on device type, the paper diagnostics market has been classified as diagnostic devices, monitoring devices. Among them, the diagnostic device segment is experiencing growth in the paper diagnostic market due to several factors driving demand for innovative and reliable diagnostic technologies. Diagnostic devices encompass a wide range of instruments, platforms, and systems used for performing diagnostic tests, analyzing samples, and interpreting results. These devices play a crucial role in healthcare delivery by enabling accurate and timely diagnosis of various medical conditions. Furthermore, growing awareness of preventive healthcare and the importance of early disease detection has led to an increased emphasis on screening programs and regular health checks.

Based on application, the market is segmented clinical diagnostics, food quality testing, and environmental monitoring. The clinical diagnostics category is expected to witness the highest CAGR during the forecast period. In the paper diagnostic market, clinical diagnostics refer to the application of paper-based diagnostic tests and devices for diagnosing, monitoring, and managing various medical conditions and diseases in clinical settings. Clinical diagnostics encompasses a wide range of applications, including infectious disease testing, chronic disease management, cancer screening, and monitoring of biomarkers or physiological parameters.

Based on the End-User, the Paper Diagnostics market has been classified into home healthcare, assisted living healthcare facilities, hospital and clinics, others. Among them, the hospital and clinics category is to witness higher adoption of Paper Diagnostics during the forecast period. The hospital and clinics segment in the end-user segment of the paper diagnostic market is experiencing growth due to several factors driving demand for rapid, cost-effective, and accessible diagnostic solutions in healthcare settings. Hospitals and clinics serve as primary points of care for patients seeking diagnosis, treatment, and management of various medical conditions. Furthermore, there is a growing demand for point-of-care testing in hospitals and clinics, driven by the need for rapid diagnosis, treatment monitoring, and patient management. Paper-based diagnostic tests offer advantages such as rapid turnaround time, ease of use, and portability, making them well-suited for POCT applications in healthcare settings.

For a better understanding of the market adoption of the Paper Diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America Paper Diagnostics market is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic diseases such as cardiovascular disease, liver disorder, diabetes and many more and growing awareness of paper diagnostics among healthcare professionals and the general population, development of advanced techniques and the rise in treatment option. For instance, in 2019, according to CDC, Every year, about 805,000 people in the United States have a heart attack. About 1 in 5 heart attacks are silent, the damage is done, but the person is not aware of it.

Some of the major players operating in the market include Bio-Rad Laboratories, Inc., BIOMERIEUX., Abbott, Siemens Healthcare Private Limited, Micro Essential Laboratory Inc, Abingdon Health, AnteoTech, Bioneer Corporation, EKF Diagnostics Holdings plc, Acon Laboratories, Inc

1MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Paper Diagnostics Market
2.2.Research Methodology of the Paper Diagnostics Market
2.4.Respondent Profile

3MARKET SYNOPSIS

4EXECUTIVE SUMMARY

5IMPACT OF COVID-19 ON THE PAPER DIAGNOSTICS MARKET

6GLOBAL PAPER DIAGNOSTICS MARKET REVENUE, 2020-2030F

7MARKET INSIGHTS BY KIT TYPE

7.1.Lateral Flow Assays
7.2.Dipsticks
7.3.Paper Based Microfluidics

8MARKET INSIGHTS BY DEVICE TYPE

8.1.Diagnostic Devices
8.2.Monitoring Devices

9MARKET INSIGHTS BY APPLICATION

9.1.Clinical Diagnostics
9.2.Food Quality Testing
9.3.Environmental Monitoring

10MARKET INSIGHTS BY END-USERS

10.1.Home Healthcare
10.2.Assisted Living Healthcare Facilities
10.3.Hospital and Clinics
10.4.Others

11MARKET INSIGHTS BY REGION

11.1NORTH AMERICA PAPER DIAGNOSTICS MARKET
- 11.1.1.U.S.
- 11.1.2.Canada
- 11.1.3.Rest of North America
11.2EUROPE PAPER DIAGNOSTICS MARKET
- 11.2.1.Germany
- 11.2.2.U.K.
- 11.2.3.France
- 11.2.4.Italy
- 11.2.5.Spain
- 11.2.6.Rest of Europe
11.3ASIA PACIFIC PAPER DIAGNOSTICS MARKET
- 11.3.1.China
- 11.3.2.Japan
- 11.3.3.India
- 11.3.4.Rest of Asia-Pacific
11.4REST OF THE WORLD PAPER DIAGNOSTICS MARKET